FDA warns of rare vision-loss side effect from GLP-1 drugs
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.
100%
1 vote cast by the community
FLIC Trust Score70 / 100
How FLIC Trust Scores workFLIC Trust Scores turn community ratings into a 0–100 signal about how readers assess a story. Fake News votes lower the score, while Liberal, Conservative, and Independent classifications support it. The formula also rewards a balanced split between Liberal and Conservative ratings instead of treating one political viewpoint as automatically more trustworthy. Scores can change as more people vote and represent community judgment, not a factual verdict or substitute for reading the original reporting. Learn more about how FLIC works.